Loading ...
Last updated at 17 Jul 2024 12:36 AM
Director
DIN: 01746508
Ramesh Singh Rawat is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at J.V.R.Y. TRADING PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01746508.Ramesh Singh Rawat has previously been associated with 2 companies in roles such as Additional Director and Director.Ramesh Singh Rawat is currently involved in 2 different roles. Their most recent position is with GRAPPLE MEDICARE PRIVATE LIMITED as a Additional Director. The first company Ramesh Singh Rawat was appointed to as a director was J.V.R.Y. TRADING PRIVATE LIMITED. Ramesh Singh Rawat has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Ramesh Singh Rawat is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at J.V.R.Y. TRADING PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01746508.Ramesh Singh Rawat has previously been associated with 2 companies in roles such as Additional Director and Director.Ramesh Singh Rawat is currently involved in 2 different roles. Their most recent position is with GRAPPLE MEDICARE PRIVATE LIMITED as a Additional Director. The first company Ramesh Singh Rawat was appointed to as a director was J.V.R.Y. TRADING PRIVATE LIMITED. Ramesh Singh Rawat has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
3y 7m 1y 10m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| J.V.R.Y. TRADING PRIVATE LIMITED | Director | 09-May-2008 |
| GRAPPLE MEDICARE PRIVATE LIMITED | Additional Director | 03-Mar-2016 |